Is NCT03376997 results overdue?

Yes — results are overdue. Primary completion was 2018-02-16; the FDAAA-801 reporting deadline (2019-02-16) passed 2728 days ago and no results are posted on ClinicalTrials.gov.

Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects

NCT ID	NCT03376997 ↗
Sponsor	Eisai Inc. (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-02-16 (ACTUAL)
Reporting deadline	2019-02-16 (completion + 365d)
Days overdue	2728
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `c0ab84bd5ec3b3d5…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03376997. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.